Developing an extended-release version of an opioid for new indications.
Industry: Health Care
First Day Return: -21.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/05/2019 |
Offer Price | $10.00 |
Price Range $10.00 - $10.00 | |
Offer Shares (mm) | 5.5 |
Deal Size ($mm) | $55 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/07/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $55 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New Haven, CT, United States |
Founded | 2011 |
Employees at IPO | 16 |
Website www.trevitherapeutics.com |